0001615219-20-000027.txt : 20200325
0001615219-20-000027.hdr.sgml : 20200325
20200325180305
ACCESSION NUMBER: 0001615219-20-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200323
FILED AS OF DATE: 20200325
DATE AS OF CHANGE: 20200325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosenblum Mark J
CENTRAL INDEX KEY: 0001329154
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36812
FILM NUMBER: 20743411
MAIL ADDRESS:
STREET 1: 3990 SPRING VALLEY ROAD, APT. 1218
CITY: DALLAS
STATE: TX
ZIP: 75244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001615219
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465087339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
BUSINESS PHONE: 346-772-0346
MAIL ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
FORMER COMPANY:
FORMER CONFORMED NAME: Flex Pharma, Inc.
DATE OF NAME CHANGE: 20140730
4
1
wf-form4_158517376702567.xml
FORM 4
X0306
4
2020-03-23
0
0001615219
Salarius Pharmaceuticals, Inc.
SLRX
0001329154
Rosenblum Mark J
C/O SALARIUS PHARMACEUTICALS, INC.
2450 HOLCOMBE BLVD., SUITE J - 608
HOUSTON
TX
77021
0
1
0
0
Exec VP Finance, CFO
Common Stock
0.61
2020-03-23
4
A
0
30000
0
A
2030-03-22
Common Stock
30000.0
30000
D
25% of the options granted are fully vested on March 23, 2021, and quarterly vesting of the remaining options over 3 years
/s/ Mark J. Rosenblum
2020-03-25